Triple-Negative Breast Cancer: Sandra's Survivor Story

Patient Info: Sandra Monsonís, Female, 40s

Biomarkers: Triple-negative breast cancer; BRCA-positive

As of November 2021, Sandra felt healthy and happy after treatment for triple-negative breast cancer, BRCA-positive testing, double mastectomy, implant complication care, external prosthesis, and ovary removal to reduce future cancer risk.

Ovarian Cancer: Shelley's Patient Story

Patient Info: Shelley O’Keefe, female

Shelley was nearing the end of chemotherapy, rebuilding her strength, and returning to demanding golf activity with strong family and community support.

Gastric Cancer: Rosie's Patient Story

Patient Info: Rosie Rosanna Fiorino, Under 40

Rosie described herself as a stomach-cancer survivor and celebrated 17 years since total gastrectomy while continuing patient-support work.

Stage III Invasive Lobular Carcinoma: Martha's Survivor Story

Patient Info: Martha, Female, 40s | Stage III

Martha completed chemotherapy, bilateral mastectomies and 30 radiation treatments and remained on Tamoxifen as part of a planned 10-year course.

Lobular Breast Cancer AllianceRead more →

Breast Cancer: Kathleen's Survivor Story

Patient Info: Kathleen Shaffer, Female

As of November 2021, Kathleen was 10 months after lymph vessel transfer surgery and free of lymphedema symptoms after earlier breast cancer treatment; the story does not report formal cancer stage or recurrence status.

Cleveland ClinicRead more →

Kidney Injury During Nivolumab Treatment for Stage IV Gastric Cancer

Patient Info: Anonymized, Male, 60s | Stage IV

Kidney function and proteinuria improved after nivolumab was stopped, but the gastric cancer progressed. Restarted nivolumab was ineffective, and treatment was changed to irinotecan.

PubMed CentralRead more →

Kidney Disease During Treatment for Metastatic Gastric Cancer

Patient Info: Anonymized, Male, 70+ | Stage Metastatic/Advanced

Metastatic Site: liver

His condition worsened with nephrotic syndrome, malnutrition, treatment side effects, and progressing metastases. He died 5 months after the kidney biopsy following a fatal cerebral bleed.

PubMed CentralRead more →

Breast Cancer: Brian's Patient Story

Patient Info: Brian Chrobak, Male, Under 40

Biomarkers: Hormone receptor-positive

Brian had completed neoadjuvant chemotherapy and surgery and was preparing to begin radiation and hormone therapy with curative intent. Tests showed no evidence of spread beyond the breast and axillary lymph nodes.

Cleveland ClinicRead more →

Stage I Invasive Ductal Carcinoma: Kim's Survivor Story

Patient Info: Kim Brisky, Female | Stage I

As of October 2021, Kim had completed chemotherapy and double mastectomy with reconstruction for Stage I ductal breast cancer, with clean margins and no signs of cancer after surgery.

Cleveland ClinicRead more →

BRCA1 Breast Cancer: Muriel's Survivor Story

Patient Info: Muriel Verger, Female, Under 40

Biomarkers: BRCA1 mutation

As of October 2021, Muriel described having completed about 9 months of treatment for triple-negative breast cancer diagnosed in 2015 and focused her message on survivorship, body image, and early detection.

YouTube (FR search)Read more →

Stage IV BRCA2 Invasive Lobular Carcinoma: Julie's Patient Story

Patient Info: Julie, Female, Under 40 | Stage IV

Biomarkers: BRCA2 mutation

Metastatic Site: Bone

Julie was first staged IIA with lobular breast cancer in 2019, then learned after chemotherapy, surgery, and radiation that the cancer had spread to her bones, making it Stage IV metastatic disease.

Lobular Breast Cancer AllianceRead more →

Ovarian Cancer: Dana's Patient Story

Patient Info: Dana Kivel, female

Dana was living with recurrent, metastatic granulosa cell ovarian cancer and taking an aromatase inhibitor for a current tumor.

Stage IV Lung Cancer: Steve's Patient Story

Patient Info: Steve Castellaw, 70+ | Stage IV

Metastatic Site: right pelvis, L1 and L2 vertebrae, skull

After about 2 years on sotorasib, Steve had a large reduction in tumor size and his latest scans continued to look good while he returned to golf, exercise, and normal daily life.

Stage IV HER2-Positive Gastric Cancer: Bryan's Patient Story

Patient Info: Bryan Chagolla, Male, Under 40 | Stage IV

Biomarkers: HER2-positive

Metastatic Site: liver

Bryan had a strong response to trastuzumab deruxtecan in 2021. He died on May 13, 2022, surrounded by loved ones.

Colorectal Cancer: Barbara's Survivor Story

Patient Info: Barbara, Female, 40s

As of October 2021, Barbara described life after completed colon-cancer treatment, including survivorship, parenting, and a stronger perspective; recurrence was not described in this edited video.

The Patient StoryRead more →

Stage IV Breast Cancer: Màrius's Patient Story

Patient Info: Màrius, Male | Stage IV

Metastatic Site: Bone: vertebra/cervical spine and ribs

As of October 2021, Màrius was living with metastatic male breast cancer described as dormant on lifelong medication after chemotherapy, radiation, 3 operations, and cyclin-inhibitor treatment.

Stage III Invasive Lobular Carcinoma: Angie's Patient Story

Patient Info: Angie, Female | Stage III

Angie completed 4 AC, 12 Taxol, and 30 rounds of radiation for Stage III grade 3 ILC, then continued Arimidex for a planned 10 years as of September 2021.

Lobular Breast Cancer AllianceRead more →

Stage I HER2-Positive Invasive Ductal Carcinoma: Tammy's Patient Story

Patient Info: Tammy, Female | Stage I

Biomarkers: HER2-positive; triple-positive breast cancer

As of September 2021, this story segment described the start of Tammy’s adjuvant treatment plan after HER2-positive, triple-positive Stage I invasive ductal carcinoma was found; no later outcome was stated in this record.

YouTube — Tammy Salamone - The Pink SurvivorRead more →

A Severe Delayed Immune Reaction After Treatment for Metastatic Colon Cancer

Patient Info: Anonymized, Male, 70+ | Stage IV

Metastatic Site: liver

He recovered from repeated episodes of severe cytokine release syndrome after prolonged corticosteroids, completed adjuvant FOLFOX and CV301 without nivolumab, and had no further CRS episodes.

PubMed CentralRead more →

Stage IV gastric cancer treated with chemotherapy and hyperthermia in a patient with a vagus nerve stimulator

Patient Info: Anonymized, male, 50s | Stage IV

Metastatic Site: para-aortic lymph nodes, peritoneum

The gastric tumors and lymph-node disease initially shrank during treatment, but peritoneal dissemination developed. He died from progressive gastric cancer 8 months after treatment began.

PubMed CentralRead more →

Triple-negative breast cancer first discovered through a duodenal metastasis

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: ER-negative; PR-negative; HER2-negative; CK7-positive; GATA3-positive; vimentin-positive; CDX2-negative; CK20-negative., triple negative

Metastatic Site: duodenum

She died two days after choosing comfort-focused care, following rapid decline from metastatic triple-negative breast cancer with duodenal involvement and small-bowel obstruction.

PubMed CentralRead more →

Stage IV Invasive Lobular Carcinoma: Carol's Survivor Story

Patient Info: Carol, Female, 60s | Stage IV

Metastatic Site: Bone

Carol had de novo Stage IV breast cancer with bone metastases, achieved complete remission after chemotherapy, stayed on daily Letrozole for 10 years, then returned to NED/no active disease after Kisqali and Faslodex for bone progression.

Lobular Breast Cancer AllianceRead more →

Stage IV gastric cancer with low platelets managed so chemotherapy could continue

Patient Info: Anonymized, female, 60s | Stage IV

Chemotherapy was able to continue after partial splenic embolization, but the gastric cancer later progressed and she died from the disease.

PubMed CentralRead more →

Stage IV gastric cancer with low platelets managed so chemotherapy could continue — Case 2

Patient Info: Anonymized, female, 70+ | Stage IV

After partial splenic embolization, her platelet count recovered and thrombocytopenia did not recur. She was receiving second-line ramucirumab plus paclitaxel at the latest follow-up.

PubMed CentralRead more →